Search

everythinglearnresearchcommunity

for

Search:↓

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

VDAC2 promotes cell death in cashmere goat hair follicles through the P53 pathway.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

High LH levels cause hair loss by damaging and aging hair follicles.

New treatments for hair loss show promise with advanced therapies and better targeting.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Immune cells are crucial for hair growth and preventing hair loss.

Wnt and Shh signaling are key in noggin-induced tumors, and blocking them can slow tumor growth.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Pharmacists play a key role in health education and managing treatments for conditions like hair loss and smoking cessation.

Glucocorticoids can cause various health issues, but some treatments may help reduce these effects.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

EGFR helps protect hair follicles from damage and scarring.

Acne patients have higher skin mTORC1 activity, which is reduced by isotretinoin treatment.

DKK2 and SOSTDC1 together are necessary for the normal timing of the first regression phase in the hair growth cycle.

Blocking EGFR can lead to hair loss due to inflammation and stem cell damage.

The enzyme sEH is important for hair growth and its inhibition could help treat hair loss.

Loss of TET2 increases the risk of skin and oral cancer.

Understanding molecular mediators can improve skin healing treatments.

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.